glp 1 infographic The unknown trajectory of GLP-1 use KFF's latest Health Tracking Poll
Description
The magnitude of effect is completely different
116.Zealand Pharma
NICE guidance (NG28 for type 2 diabetes, TA875 for semaglutide 2.4 mg, and TA664 for liraglutide 3 mg) recommends regular monitoring of patients on GLP-1 therapy, with particular attention to tolerability and adverse effects
AgeRejuvenation is an independent functional medicine and longevity clinic with no affiliation to these health systems
And the patient populations among studies are different
